Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanyang Yixinkang
- Development stage
- Phase 2
- Lead developer
- Jilin Academy of Chinese Medicine Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sanyang Yixinkang is a Traditional Chinese Medicine (TCM) preparation developed by the Jilin Province Academy of Traditional Chinese Medicine for the treatment of coronary heart disease and angina pectoris. Formulated to address the TCM pattern of "Qi deficiency and blood stasis," the drug typically contains a combination of animal-derived and herbal extracts, including sheep heart, sheep blood, and sheep kidney (the "Three Yangs"), alongside botanical components. Pharmacological research indicates that Sanyang Yixinkang improves myocardial blood supply, protects cardiac cells from ischemic injury, and regulates vascular endothelial function by modulating levels of nitric oxide and endothelin-1. It also exhibits anti-platelet aggregation properties and helps reduce blood viscosity, thereby alleviating clinical symptoms such as chest pain and palpitations in patients with chronic stable angina.
- Brand names
- Sanyang Yixinkang
- Other names
- Sanyang Yixinkang CapsuleSanyang Yixinkang JiaonangSan-Yang-Yi-Xin-Kang
02
Targets
ET-1 (Endothelin-1)NO2- (Nitrite)
Beyond the preview
Go deeper on Sanyang Yixinkang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanyang Yixinkang.